Hot Features
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Deep Track Capital, LP | Institution | 3 055 027 | 5,81% | US$ 41,58M | 2026-05-29 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 3 055 027 | 5,81% | US$ 41,58M | 2026-05-29 |
| TCG Crossover Management, LLC | Institution | 3 017 120 | 5,74% | US$ 41,06M | 2026-05-05 |
| TCG Crossover Fund II, L.P. | Institution | 3 017 120 | 5,74% | US$ 41,06M | 2026-05-05 |
| FMR LLC | Institution | 2 879 481 | 5,48% | US$ 39,19M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 2 710 817 | 5,16% | US$ 36,89M | 2026-05-22 |
| Point72 Associates, LLC | Institution | 2 710 817 | 5,16% | US$ 36,89M | 2026-05-22 |
| BVF Partners L.P. | Institution | 2 677 385 | 5,09% | US$ 36,44M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 2 162 684 | 4,11% | US$ 29,43M | 2026-03-31 |
| Caligan Partners, LP | Institution | 1 635 023 | 3,11% | US$ 22,25M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 1 447 651 | 2,75% | US$ 19,70M | 2026-03-31 |
| Avoro Capital Advisors LLC | Institution | 1 410 000 | 2,68% | US$ 19,19M | 2026-03-31 |
| Avoro Life Sciences Fund LLC | Institution | 1 410 000 | 2,68% | US$ 19,19M | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 1 340 840 | 2,55% | US$ 18,25M | 2026-03-31 |
| Nantahala Capital Management, LLC | Institution | 1 235 000 | 2,35% | US$ 16,81M | 2026-03-31 |
| UBS Asset Management AG | Institution | 1 141 980 | 2,17% | US$ 15,54M | 2026-03-31 |
| Affinity Healthcare Fund, LP | Institution | 1 051 054 | 2,00% | US$ 14,30M | 2026-01-22 |
| Biotechnology Value Fund II, L.P. | Institution | 1 035 952 | 1,97% | US$ 14,10M | 2026-03-31 |
| Farallon Capital Management, L.L.C. | Institution | 916 000 | 1,74% | US$ 12,47M | 2026-03-31 |
| RTW Investments, LP | Institution | 856 962 | 1,63% | US$ 11,66M | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 854 000 | 1,62% | US$ 11,62M | 2026-03-31 |
| Millennium Management LLC | Institution | 835 484 | 1,59% | US$ 11,37M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 731 586 | 1,39% | US$ 9,96M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 719 694 | 1,37% | US$ 9,80M | 2026-03-31 |
| Logos Global Management, L.P. | Institution | 675 000 | 1,28% | US$ 9,19M | 2026-03-31 |
| Logos Global Master Fund, LP | Institution | 675 000 | 1,28% | US$ 9,19M | 2026-03-31 |
| RA Capital Management, L.P. | Institution | 662 968 | 1,26% | US$ 9,02M | 2026-03-31 |
| Bank of America Corporation | Institution | 643 000 | 1,22% | US$ 8,75M | 2026-03-31 |
| Mr. Patrick Crutcher | Initiés | 549 467 | 1,05% | US$ 7,48M | 2025-08-06 |
| Commodore Capital LP | Institution | 483 000 | 0,92% | US$ 6,57M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 475 165 | 0,90% | US$ 6,47M | 2026-03-31 |
| Jennison Associates LLC | Institution | 470 775 | 0,90% | US$ 6,41M | 2026-03-31 |
| Caption Management, LLC | Institution | 455 000 | 0,87% | US$ 6,19M | 2026-03-31 |
| Soleus Capital Management, L.P. | Institution | 441 978 | 0,84% | US$ 6,02M | 2026-03-31 |
| Atlas Diversified Master Fund, Ltd. | Institution | 439 312 | 0,84% | US$ 5,98M | 2025-12-31 |
| BNP Paribas Financial Markets SNC | Institution | 422 781 | 0,80% | US$ 5,75M | 2026-03-31 |
| Kennedy Capital Management LLC | Institution | 387 982 | 0,74% | US$ 5,28M | 2026-03-31 |
| Dv Trading, LLC | Institution | 360 064 | 0,68% | US$ 4,90M | 2026-03-31 |
| BlackRock, Inc. | Institution | 327 082 | 0,62% | US$ 4,45M | 2026-03-31 |
| Norges Bank Investment Management | Institution | 326 909 | 0,62% | US$ 4,45M | 2025-12-31 |
| Boothbay Fund Management, LLC | Institution | 324 258 | 0,62% | US$ 4,41M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 304 163 | 0,58% | US$ 4,14M | 2026-04-30 |
| Boxer Capital Management, LLC | Institution | 300 000 | 0,57% | US$ 4,08M | 2026-03-31 |
| Pivotal BioVenture Partners LLC | Institution | 295 933 | 0,56% | US$ 4,03M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.